Skip to main content
Search
Search
Advanced Search
Skip main navigation
Open access
Research Article
11 April 2025

Impact analysis of expanding antibiotic use for treatment of uncomplicated appendicitis without appendicolith

Authors: Diana Poehler https://orcid.org/0000-0001-8287-8033 [email protected], Sydney Kirsch https://orcid.org/0009-0000-4527-1910, Matthew Dempsey https://orcid.org/0000-0002-0758-2029, Kristen Giombi https://orcid.org/0000-0002-8788-0391, and Olga Khavjou https://orcid.org/0000-0003-0805-0769Author Info & Affiliations
Volume 14, Number 5
https://doi.org/10.57264/cer-2024-0234
PDFFormats

Abstract

Aim: Approximately 20% of patients with uncomplicated appendicitis receive antibiotics as a first-line treatment; this study explores the impacts of expanding patient uptake of first-line antibiotics for appendicitis treatment. Materials & methods: We model the impacts on the patient, caregiver, payer and total societal costs associated with expanding antibiotics use from 20 to 50% for patients with appendicitis through use of a decision-tree model. Results: Increasing antibiotics uptake to 50% of eligible appendicitis patients is expected to decrease overall societal economic costs by $192 million, and these savings are driven by a $493 million reduction in initial treatment costs. For patients and their caregivers, out-of-pocket costs are expected to decrease by $18 million, appendectomies by 27,410 and missed work hours by 639,682. Conclusion: Increasing national uptake of antibiotics for the treatment of appendicitis may reduce patient, payer and total societal costs with minimal impact to patient health outcomes. An expansion may also decrease the total number of appendectomies, appendectomy-related medical complications, and lost wages for patients and caregivers, with minimal decreases in the number of appendiceal cancer cases treated early.

Plain language summary: Understanding the impacts of increased antibiotic use as an alternative to appendectomy for appendicitis

What is this article about?

Approximately 300,000 people in the USA experience inflammation in their appendix each year, a condition that is referred to as appendicitis. Appendicitis may cause severe abdominal pain and requires immediate medical treatment to avoid life-threatening infections. Most patients undergo an appendectomy, which is surgical procedure that removes the appendix, to resolve their appendicitis. Appendectomies are generally curative for appendicitis and may help detect appendiceal cancers at earlier stages; however, appendectomies can be costly and may result in surgical complications. This study expands an existing clinical trial to understand the costs and implications to patients and caregivers of increased antibiotic use in the USA.

What methodology/protocol is described?

Currently, about 20% of eligible patients receive antibiotics to treat their appendicitis. We used a simulation model to assess the patient and payer impacts of expanding uptake of antibiotics to 50% of eligible patients. The model evaluated changes in health outcomes, healthcare utilization, patient and caregiver work loss and costs associated with the expansion of antibiotics treatment using a 5-year time horizon.

What do the results mean?

Increasing national uptake of antibiotics for the treatment of appendicitis from 20 to 50% may reduce patient, payer and total societal costs with minimal impact to patient health outcomes. The expansion would decrease the total number of appendectomies, appendectomy-related medical complications and wages, with minimal decreases in the number of appendiceal cancer cases treated early.

Supplementary Material

File (supplementary data.docx)

References

1.
Addiss DG, Shaffer N, Fowler BS, Tauxe RV. The epidemiology of appendicitis and appendectomy in the United States. Am. J. Epidemiol. 132(5), 910–925 (1990).
PubMed
Google Scholar
2.
Talan DA, Saverio SD. Treatment of acute uncomplicated appendicitis. N. Engl. J. Med. 385(12), 1116–1123 (2021).
PubMed
Google Scholar
3.
Flum DR, Davidson GH, Heagerty PJ et al. Comparing Antibiotics versus Surgery for Treating Appendicitis—The CODA Study. (2022). Available at: https://doi.org/10.25302/01.2023.PCS.140924099
Google Scholar
4.
Hansson J, Korner U, Khorram-Manesh A, Solberg A, Lundholm K. Randomized clinical trial of antibiotic therapy versus appendicectomy as primary treatment of acute appendicitis in unselected patients. Br. J. Surg. 96(5), 473–481 (2009).
PubMed
Google Scholar
5.
Korah M, Tennakoon L, Knowlton LM et al. Management of uncomplicated appendicitis in adults: a nationwide analysis from 2018 to 2019. J. Surg. Res. 298, 307–315 (2024).
PubMed
Google Scholar
6.
Salminen P, Paajanen H, Rautio T et al. Antibiotic therapy vs appendectomy for treatment of uncomplicated acute appendicitis: the APPAC randomized clinical trial. J. Am. Med. Assoc. 313(23), 2340–2348 (2015).
Google Scholar
7.
Salminen P, Tuominen R, Paajanen H et al. Five-year follow-up of antibiotic therapy for uncomplicated acute appendicitis in the APPAC randomized clinical trial. J. Am. Med. Assoc. 320(12), 1259–1265 (2018).
Google Scholar
8.
Flum DR, Davidson GH, Monsell SE et al. A randomized trial comparing antibiotics with appendectomy for appendicitis. N. Engl. J. Med. 383(20), 1907–1919 (2020).
PubMed
Google Scholar
9.
Babington EA. Appendicoliths, the little giants: a narrative review. Radiography 29(1), 1–7 (2023).
PubMed
Google Scholar
10.
US Department of Veterans Affairs. Budget Impact Analysis. (2023). Available at: https://www.herc.research.va.gov/include/page.asp?id=budget-impact-analysis
Google Scholar
11.
Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost-Effectiveness in Health and Medicine. Oxford University Press, UK (2016).
Google Scholar
12.
US Census Bureau. Annual Estimates of the Resident Population by Single Year of Age and Sex for the United States. Available at: https://www.census.gov/data/tables/time-series/demo/popest/2020s-national-detail.html
Google Scholar
13.
Buckius MT, McGrath B, Monk J et al. Changing epidemiology of acute appendicitis in the United States: study period 1993–2008. J. Surg. Res. 175(2), 185–190 (2012).
PubMed
Google Scholar
14.
Flum DR, Kessler LG, Monsell SE, Allen GI. (2024). [Personal communication].
Google Scholar
15.
Bom WJ, Scheijmans JC, Salminen P, Boermeester MA. Diagnosis of uncomplicated and complicated appendicitis in adults. Scand. J. Surg. 110(2), 170–179 (2021).
PubMed
Google Scholar
16.
Potey K, Kandi A, Jadhav S, Gowda V. Study of outcomes of perforated appendicitis in adults: a prospective cohort study. Ann. Med. Surg. (Lond.) 85(4), 694–700 (2023).
PubMed
Google Scholar
17.
Kolla BC, Petersen A, Chengappa M et al. Impact of adjuvant chemotherapy on outcomes in appendiceal cancer. Cancer Med. 9(10), 3400–3406 (2020).
PubMed
Google Scholar
18.
Schumm MA, Childers CP, Wu JX, Zanocco KA. Cost saving of short hospitalization nonoperative management for acute uncomplicated appendicitis. J. Surg. Res. 255, 77–85 (2020).
PubMed
Google Scholar
19.
Talan DA, Moran GJ, Krishnadasan A et al. Analysis of outcomes associated with outpatient management of nonoperatively treated patients with appendicitis. JAMA Netw. Open 5(7), e2220039 (2022).
PubMed
Google Scholar
20.
Healthcare Cost and Utilization Project (HCUPnet)Version. (2024). Available at: https://datatools.ahrq.gov/hcupnet/
Google Scholar
21.
Tsai T. (2024). [Personal communication].
Google Scholar
22.
Ferguson DM, Arshad SA, Avritscher EBC et al. Costs associated with postoperative intra-abdominal abscess in pediatric perforated appendicitis: a retrospective cohort study. Surgery 172(1), 212–218 (2022).
PubMed
Google Scholar
23.
Shah DN, Aitken SL, Barragan LF et al. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. J. Hosp. Infect. 93(3), 286–289 (2016).
PubMed
Google Scholar
25.
Ladabaum U, Mannalithara A, Weng Y et al. Comparative effectiveness and cost-effectiveness of colorectal cancer screening with blood-based biomarkers (liquid biopsy) vs fecal tests or colonoscopy. Gastroenterology 167(2), 378–391 (2024).
PubMed
Google Scholar
26.
Sceats LA, Ku S, Coughran A et al. Operative versus nonoperative management of appendicitis: a long-term cost effectiveness analysis. MDM Policy Pract. 4(2), 2381468319866448 (2019).
Google Scholar
27.
US Bureau of Labor Statistics. Consumer Price Index for All Urban Consumers: Medical Care in U.S. City Average [CPIMEDNS]. Available at: https://fred.stlouisfed.org/series/CPIMEDNS
Google Scholar
28.
MEPS: Medical Expenditure Panel Survey 2016–2019 data Version. (2024). Available at: https://meps.ahrq.gov/datastats/download_data_files.jsp
Google Scholar
29.
Labor Force Participation Rate (CIVPART) Version. (2024). Available at: https://fred.stlouisfed.org/series/CIVPART
Google Scholar
30.
CPS Annual Social and Economic (March) Supplement Version. (2021).
Google Scholar
31.
Statistics USBoL. EMPLOYER COSTS FOR EMPLOYEE COMPENSATION – MARCH 2024. Available at: https://www.bls.gov/news.release/pdf/ecec.pdf
Google Scholar
32.
Ray KN, Chari AV, Engberg J, Bertolet M, Mehrotra A. Opportunity costs of ambulatory medical care in the United States. Am. J. Manag. Care 21(8), 567–574 (2015).
PubMed
Google Scholar
34.
Rosen JE, Agrawal N, Flum DR, Liao JM. Willingness to undergo antibiotic treatment of acute appendicitis based on risk of treatment failure. Brit. J. Surg. 108(11), e361–e363 (2021).
PubMed
Google Scholar
35.
Adams UC, Herb JN, Akinkuotu AC et al. Nonoperative management versus laparoscopic appendectomy in children: a cost-effectiveness analysis. J. Surg. Res. 283, 929–936 (2023).
PubMed
Google Scholar
36.
CODA Collaborative. Antibiotics versus appendectomy for acute appendicitis—longer-term outcomes. N. Engl. J. Med. 385(25), 2395–2397 (2021).
PubMed
Google Scholar
37.
Writing Group for the CODA Collaborative. Appendiceal neoplasms in patients treated with antibiotics for acute appendicitis: secondary analysis of the CODA randomized clinical trial. Brit. J. Surg. 110(12), 1659–1662 (2023).
PubMed
Google Scholar
|